TY - PAT
T1 - Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases
AU - Katzenellenbogen, John A
AU - Tiwari-Woodruff, Seema Kaushalya
AU - Kim, Sung Hoon
AU - Katzenellenbogen, Benita
PY - 2023/6/13
Y1 - 2023/6/13
N2 - 4-Hydroxyphenyl-2H-indazol-5-ol compounds are estrogen receptor beta ligands that have immunomodulatory properties and increase oligodendrocyte survival, differentiation, and remyelination. The compounds, compositions, and kits are useful in the treatment of multiple sclerosis and endometriosis.
AB - 4-Hydroxyphenyl-2H-indazol-5-ol compounds are estrogen receptor beta ligands that have immunomodulatory properties and increase oligodendrocyte survival, differentiation, and remyelination. The compounds, compositions, and kits are useful in the treatment of multiple sclerosis and endometriosis.
M3 - Patent
M1 - 11673866
ER -